
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
While we often think of childhood as a carefree time of life, children and adolescents do in fact experience high levels of stress and anxiety-sometimes on a debilitating scale. For the clinician addressing these issues, recognizing the varying types and causes of anxiety is only half the battle.
Please click here to go directly to the CME site. (Registration required)






